Literature DB >> 11745474

Cancer risks in women with 2 breast or ovarian cancers: clues to genetic cancer susceptibility.

H S Evans1, C M Lewis, D Robinson, C M Bell, H Møller, S V Hodgson.   

Abstract

Women diagnosed with 2 cancers of the breast and/or ovary are at higher risk of developing subsequent cancers. Using registrations from the Thames Cancer Registry, we quantified the risks at different cancer sites. Increased risks were found for cancers that are part of the BRCA1 and BRCA2 tumour spectrum: oropharyngeal cancer, malignant melanoma of the skin (BRCA2) and colon cancer (BRCA1). We also found significantly increased risks of myeloid leukaemia (probably due to radiotherapy) and of cancer of the corpus uteri (which may be due to hormonal factors). Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11745474     DOI: 10.1002/ijc.1534

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

Review 1.  Hereditary breast and ovarian cancer: review and future perspectives.

Authors:  Michael P Lux; Peter A Fasching; Matthias W Beckmann
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

2.  Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.

Authors:  Luna Kadouri; Mark Temper; Tal Grenader; Dvorah Abeliovich; Tamar Hamburger; Tamar Peretz; Michal Lotem
Journal:  Fam Cancer       Date:  2008-08-05       Impact factor: 2.375

3.  Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer.

Authors:  Pavel Elsakov; Juozas Kurtinaitis; Valerij Ostapenko
Journal:  Fam Cancer       Date:  2007-05-23       Impact factor: 2.375

Review 4.  The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers.

Authors:  Bernard Friedenson
Journal:  BMC Cancer       Date:  2007-08-06       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.